Eventide Asset Management - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$1,735,000
-32.0%
113,6000.0%0.07%
-40.0%
Q1 2018$2,553,000
-74.7%
113,600
-66.1%
0.12%
-77.1%
Q4 2017$10,078,000
-20.1%
334,7000.0%0.52%
-26.6%
Q3 2017$12,608,000
+35.1%
334,7000.0%0.72%
+23.1%
Q2 2017$9,335,000
-18.9%
334,7000.0%0.58%
-23.8%
Q1 2017$11,507,000
+19.2%
334,7000.0%0.76%
+21.3%
Q4 2016$9,653,000
-9.3%
334,7000.0%0.63%
-3.4%
Q3 2016$10,647,000
-2.0%
334,7000.0%0.65%
-2.3%
Q2 2016$10,864,000
+16.1%
334,7000.0%0.66%
+27.2%
Q1 2016$9,358,000
-21.6%
334,7000.0%0.52%
-12.2%
Q4 2015$11,932,000
+10.4%
334,700
+2.4%
0.60%
-5.1%
Q3 2015$10,804,000
-4.8%
326,700
+20.5%
0.63%
+2.3%
Q2 2015$11,354,000
+28.5%
271,1000.0%0.61%
-7.7%
Q1 2015$8,835,000
-34.2%
271,100
-35.9%
0.66%
-54.7%
Q4 2014$13,437,000
+28.2%
423,2000.0%1.47%
+0.3%
Q3 2014$10,478,000
+9.6%
423,2000.0%1.46%
+12.5%
Q2 2014$9,560,000
+103.1%
423,200
+118.7%
1.30%
+77.8%
Q1 2014$4,708,000
+7.4%
193,500
+10.3%
0.73%
-45.9%
Q4 2013$4,383,000175,4001.35%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders